Wonkyung Byon

Impact of censoring data below an arbitrary quantification limit on structural model misspecification

Courtney V. Fletcher, Wonkyung Byon, Richard C. Brundage, 2008, Journal of Pharmacokinetics and Pharmacodynamics.

Evaluation of the agonist PET radioligand [11C]GR103545 to image kappa opioid receptor in humans: Kinetic model selection, test–retest reproducibility and receptor occupancy by the antagonist PF-04455242

Richard E. Carson, David Weinzimmer, Nabeel Nabulsi, 2014, NeuroImage.

Quantitative PK–PD Model-Based Translational Pharmacology of a Novel Kappa Opioid Receptor Antagonist Between Rats and Humans

Yifeng Lu, Cheng Chang, Wonkyung Byon, 2011, The AAPS Journal.

Metabolism and clinical pharmacokinetics of 2-methyl-n-(2′-(pyrrolidinyl-1-ylsulfonyl)-n-[1,1′-biphenyl]-4-yl)propran-1-amine: insights into monoamine oxidase- and CYP-mediated disposition by integration of in vitro ADME tools

Linda Wood, Wonkyung Byon, Carrie Funk, 2014, Xenobiotica; the fate of foreign compounds in biological systems.

Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review

Wonkyung Byon, Charles E. Frost, C. Frost, 2019, Clinical Pharmacokinetics.